April's Insider Flow简体 · 繁體
醫療保健 · Healthcare

XERS · Xeris Biopharma Holdings, Inc.

內部人交易(Form 4)· Insider trading · 2026-07-01 – 2026-10-22

Xeris Biopharma Holdings, Inc.(XERS)內部人交易:2026-07-01 至 2026-10-22,內部人公開市場買入 —、賣出 $2.4M;高管董事有效買入 —、有效賣出 —。最近申報 2026-10-02。

買入 Bought—
賣出 Sold$2.4M
有效買入 Effective bought—
有效賣出 Effective sold—
開啟互動頁面(K 線、成交價圖)Open interactive page →

最近申報 Recent filings

交易日內部人類型股數價格金額
2026-10-01Hecht Beth
See Remarks
賣出 Sell16,666$9.41$157KSEC
2026-10-01McCulloch Kevin
See Remarks
賣出 Sell15,000$9.41$141KSEC
2026-10-01Pieper Steven
See Remarks
賣出 Sell5,000$9.41$47KSEC
2026-09-28McCulloch Kevin
See Remarks
賣出 Sell25,000$10.00$250KSEC
2026-09-01Hecht Beth
See Remarks
賣出 Sell16,666$8.49$141KSEC
2026-09-01McCulloch Kevin
See Remarks
賣出 Sell15,000$8.49$127KSEC
2026-09-01Pieper Steven
See Remarks
賣出 Sell5,000$8.50$42KSEC
2026-08-12Pieper Steven
See Remarks
賣出 Sell5,000$8.50$42KSEC
2026-08-03Hecht Beth
See Remarks
賣出 Sell16,666$8.01$134KSEC
2026-08-03McCulloch Kevin
See Remarks
賣出 Sell15,000$8.02$120KSEC
2026-07-06Pieper Steven
See Remarks
賣出 Sell45,000$8.52$383KSEC
2026-07-01Hecht Beth
See Remarks
賣出 Sell16,666$8.03$134KSEC
2026-07-01McCulloch Kevin
See Remarks
賣出 Sell90,000$8.03$723KSEC
「有效」= 高管或董事的公開市場主動買賣,排除 10b5-1 計劃、行權賣出、繳稅賣出、IPO/認購等。

擬出售 Form 144

預計出售日申報人股數約金額
2026-10-01Hecht Beth
Officer
16,666$159K10b5-1
2026-09-28McCulloch Kevin
Officer
70,000$637K10b5-1
2026-08-12Pieper Steven
Officer
20,000$168K10b5-1
2026-07-07Pieper Steven
Officer
27,600$231K10b5-1
2026-07-06Pieper Steven
Officer
17,400$144K10b5-1
2026-07-01McCulloch Kevin
Officer
120,000$950K10b5-1
2026-07-01Hecht Beth
Officer
49,998$396K10b5-1

內部人 Insiders

Hecht Beth、McCulloch Kevin、Pieper Steven